These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12597450)

  • 1. Prevalidation of a rat liver foci bioassay (RLFB) based on results from 1600 rats: a study report.
    Ittrich C; Deml E; Oesterle D; Küttler K; Mellert W; Brendler-Schwaab S; Enzmann H; Schladt L; Bannasch P; Haertel T; Mönnikes O; Schwarz M; Kopp-Schneider A
    Toxicol Pathol; 2003; 31(1):60-79. PubMed ID: 12597450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of mode of action of four hepatocarcinogens: a model-based approach.
    Groos J; Bannasch P; Schwarz M; Kopp-Schneider A
    Toxicol Sci; 2007 Oct; 99(2):446-54. PubMed ID: 17636249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
    Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
    Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Multiorgan Initiation-Promotion Assay for Chemical Carcinogenesis in the Wistar Rat.
    Solano ML; Rocha NS; Barbisan LF; Franchi CA; Spinardi-Barbisan AL; de Oliveira ML; Salvadori DM; Ribeiro LR; de Camargo JL
    Toxicol Pathol; 2016 Dec; 44(8):1146-1159. PubMed ID: 28245158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals.
    Ito N; Tamano S; Shirai T
    Cancer Sci; 2003 Jan; 94(1):3-8. PubMed ID: 12708466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenic potential of some pesticides in a medium-term multi-organ bioassay in rats.
    Hasegawa R; Cabral R; Hoshiya T; Hakoi K; Ogiso T; Boonyaphiphat P; Shirai T; Ito N
    Int J Cancer; 1993 May; 54(3):489-93. PubMed ID: 8509224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
    Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
    Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying influence of swine-serum-induced liver fibrosis on development of preneoplastic lesions in rat liver.
    Wada S; Kato T; Mutai M; Ozaki K; Yamaguchi S; Kim DJ; Baba-Toriyama H; Asamoto M; Ito N; Tsuda H
    Jpn J Cancer Res; 1996 Mar; 87(3):240-6. PubMed ID: 8613425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of chemopreventive influence of propolis on the rat liver altered foci development.
    Said RA; Grassi TF; Scolastici C; Alves de Lima RO; Darros BR; Barbisan LF; de Camargo JL
    Exp Toxicol Pathol; 2010 Jul; 62(4):405-12. PubMed ID: 19628380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
    Kim HC; Lee YS; Nishikawa A
    J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility.
    Greaves P; Irisarri E; Monro AM
    J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response study of N-nitrosodiethanolamine initiation of rat hepatocarcinogenesis.
    Ogawa K; Hasegawa R; Wada S; Yamaguchi S; Ito N
    Teratog Carcinog Mutagen; 1991; 11(5):245-50. PubMed ID: 1687902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medium-term bioassay for the hepatocarcinogenicity of hexachlorobenzene.
    Cabral R; Hoshiya T; Hakoi K; Hasegawa R; Ito N
    Cancer Lett; 1996 Feb; 100(1-2):223-6. PubMed ID: 8620445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of trans-4-acetylaminostilbene and 2-acetylaminofluorene at the level of tumor initiation.
    Hammerl R; Kirchner T; Neumann HG
    Chem Biol Interact; 1994 Oct; 93(1):11-28. PubMed ID: 7915206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
    Gerbracht U; Bursch W; Kraus P; Putz B; Reinacher M; Timmermann-Trosiener I; Schulte-Hermann R
    Carcinogenesis; 1990 Apr; 11(4):617-24. PubMed ID: 1691053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation-promotion model for assessment of carcinogenicity: medium-term liver bioassay in rats for rapid detection of carcinogenic agents.
    Imaida K; Fukushima S
    J Toxicol Sci; 1996 Dec; 21(5):483-7. PubMed ID: 9035059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
    Hayashi M; Ohnota H; Tamura T; Kuroda J; Shibata N; Akahane M; Moriwaki H; Machida N; Mitsumori K
    Arch Toxicol; 2004 Aug; 78(8):460-6. PubMed ID: 15034639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transferase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate.
    Ito S; Tateno C; Tuda M; Yoshitake A
    Toxicol Pathol; 1996; 24(6):690-5. PubMed ID: 8994295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.